Several biological factors can blunt or block the high from cannabis, ranging from how your body metabolizes THC to the density and sensitivity of the receptors it acts on. The experience of “not getting high” is far more common than casual conversation suggests, and it almost always has an identifiable physiological explanation rather than being “all in your head.” The reasons span genetics, tolerance, hormones, body composition, and even what else is in the cannabis you consumed.
Your Genes Shape How THC Hits Your Brain
THC does not produce the same blood concentrations or the same subjective experience in every person, and a big piece of that variation is genetic. One well-studied factor involves the CYP2C9 enzyme in your liver, which is responsible for converting THC into its metabolites. Certain variants of the CYP2C9 gene change how quickly or completely that conversion happens, altering the balance between THC itself and its breakdown products in your bloodstream.1Medical Research Archives. A study on CYP2C9 polymorphism in Puerto Rican Alzheimer’s Patients and its role in the Pharmacokinetics of Delta-9-tetrahydrocannabinol Some people end up with unusually rapid clearance of THC, meaning it gets broken down before it has much time to bind to brain receptors. Others get a skewed ratio of active-to-inactive metabolites that changes the quality or intensity of the high without necessarily eliminating it.
Beyond liver enzymes, the receptors themselves vary from person to person. The CB1 receptor is the main target THC binds to in order to produce psychoactive effects. A pilot study of specific genetic variants in the CB1 receptor gene (CNR1) found that people carrying certain minor alleles tended to report stronger subjective effects from smoked cannabis, while those without those variants reported weaker ones.2PubMed Central. Influence of Cannabinoid Receptor 1 Genetic Variants on the Subjective Effects of Smoked Cannabis The implication runs both ways: if you carry the more common versions of these gene variants, you could simply have receptors that respond less dramatically to THC. This is not something you can feel out or test at home, but it helps explain why two people sharing the same joint can have wildly different experiences.
Tolerance and Receptor Downregulation
If you used to get high and gradually stopped feeling it, the most probable explanation is tolerance. Chronic cannabis use triggers a measurable reduction in CB1 receptors across the brain. Imaging research on daily cannabis smokers confirmed that CB1 receptor availability drops with sustained use, particularly in brain regions tied to mood and cognition.3PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers With fewer receptors available, the same dose of THC produces a weaker signal. The good news from that same research is that this downregulation is reversible: receptor levels begin recovering after abstinence.
The underlying mechanism has been investigated at the molecular level. When CB1 receptors are repeatedly activated by THC, the cell tags them for destruction through a protein-recycling process. Recent work identified a specific enzyme pathway that couples CB1 receptor activation to its degradation, explaining why long-term tolerance involves not just receptors going quiet but actually being broken down and removed from the cell surface.4PubMed Central. Cannabinoid tolerance relies on CB(1) receptor ubiquitination by NEDD4L This is a more durable form of tolerance than the short-term desensitization that happens after a single session. If you have been using cannabis daily for months or years, you likely have meaningfully fewer CB1 receptors than a non-user, and simply consuming more THC runs into diminishing returns.
How You Consume It Matters More Than You Think
People who try edibles for the first time and feel nothing often assume cannabis does not work for them. But the route of administration drastically changes how much THC actually reaches your brain. When THC is swallowed, it passes through your digestive tract and liver before entering general circulation. Early research found that eating a cookie containing THC resulted in only about 6% of the THC making it into the bloodstream. When dissolved in an oil and placed in a capsule, that figure improved to roughly 10 to 20%.5ScienceDirect (Current Opinion in Food Science). Opportunities and challenges in developing orally administered cannabis edibles Compare that to smoking, where THC enters the blood through the lungs almost immediately and bypasses the liver entirely on its first pass.
This means the same milligram dose can feel like nothing eaten versus overwhelming smoked. It also means that the type of edible matters. THC dissolved in fat, particularly long-chain fats like those in oils and butter, gets absorbed through a different intestinal pathway that partly avoids the liver’s first-pass metabolism. A gummy made with a water-based THC extract may deliver less usable THC than a chocolate bar made with cannabis-infused butter, even at the same labeled dose. If you tried an edible once and felt nothing, the formulation and your stomach contents at the time were probably bigger factors than your biology.
CBD Can Actively Work Against THC
This is one of the most underappreciated reasons someone might not feel high: the other compounds in the cannabis they consumed. Cannabidiol, or CBD, has been identified as a negative allosteric modulator of the CB1 receptor.6PubMed Central. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor In plain terms, CBD binds to a different spot on the same receptor that THC targets and changes the receptor’s shape in a way that makes THC less effective at activating it. Laboratory work showed that CBD reduced both the potency and the efficacy of THC signaling through CB1 receptors.
Computational modeling supports this, suggesting that when CBD binds to the CB1 receptor alongside THC, it nudges the receptor toward an inactive state.7PLOS ONE. Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study Additional experimental work has confirmed the location of CBD’s binding site on the receptor and its dampening effect on THC activation.8PubMed. Determination of the Negative Allosteric Binding Site of Cannabidiol at the CB1 Receptor: A Combined Computational and Site-Directed Mutagenesis Study If you consumed a cannabis product with a high CBD-to-THC ratio, CBD could have been actively dialing down the high. Many hemp-derived products legally sold as “cannabis” contain much more CBD than THC by design, and some full-spectrum products have enough CBD to meaningfully interfere with the psychoactive effects of the THC they contain.
The Terpene Wild Card
Cannabis contains dozens of aromatic compounds called terpenes, the molecules responsible for the plant’s varied smells. For years, the “entourage effect” was mostly marketing language, but recent receptor-level research is finding that some terpenes genuinely modulate how THC activates CB1 receptors. Certain terpenes, including limonene, pinene, and borneol, appear to synergistically enhance THC’s activation of CB1 receptors, while others show additive effects.9PubMed. Synergistic and additive terpene-THC interactions in cannabinoid CB1 and CB2 receptors Mixtures of terpenes also showed dose-dependent CB1 activation on their own and could synergistically boost THC responses.10PubMed. Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation
This has practical implications. A THC distillate that has been stripped of its terpenes during processing may produce a qualitatively different and potentially weaker experience than a whole-plant product with an intact terpene profile, even at the same THC percentage. Concentrates, vape cartridges, and edibles made from isolates lose most or all of these compounds. If you switched from flower to a refined product and the high seemed to disappear, the missing terpenes could be part of the explanation.
Sex Hormones and Body Composition
Biological sex influences cannabis response in several ways. Animal and human research shows that males and females differ in both the pharmacokinetics (how the body handles THC) and the pharmacodynamics (how the body responds to it). Differences in muscle mass and fat distribution between males and females alter how THC is distributed and stored in the body.11PubMed Central. How important are sex differences in cannabinoid action? Estradiol in particular has been identified as a major contributor to sex-based differences in cannabinoid effects in adults.12PubMed Central. Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?
The fat-storage issue deserves its own attention. THC is highly fat-soluble. Classic research showed that after a single dose, the concentration of THC in fat tissue was ten times higher than in any other tissue examined, and it persisted in fat for two weeks. With repeated use, THC and its metabolites accumulated in fat and brain tissue.13PubMed. Delta-9-tetrahydrocannabinol: localization in body fat A person with more body fat may sequester more THC away from the brain during acute use, blunting the immediate high. Conversely, during weight loss or fasting, stored THC can be released back into circulation, which is why some former users report feeling slightly “off” during rapid weight loss even after weeks of abstinence.
Your Mindset and Environment Play a Biological Role
Expectation effects on cannabis are not just placebo hand-waving. Research on the acute effects of smoked cannabis found that the direction of effect on anxiety depended on what participants were told they were consuming. Anxiety increased after THC in people who were told they received a placebo, but decreased in others. People who expected more impairment from cannabis became more anxious after smoking it, while those who did not expect impairment became less anxious.14PubMed Central. Acute Effects of Marijuana Smoking on Negative and Positive Affect
These are not just changes in how people describe their experience. Expectations alter the neurochemical context in which THC operates. Stress hormones, baseline anxiety, and attentional focus all modulate how your endocannabinoid system responds to an outside cannabinoid. If you are in a tense, unfamiliar, or overstimulating environment, or if you approach cannabis with strong expectations (either dread or desperate hope), the subjective experience can land differently than the pharmacology alone would predict. This is the biological basis for the “set and setting” concept that recreational users have discussed for decades.
Age-Related Changes in CB1 Receptors
If cannabis used to work for you decades ago and no longer does, aging itself may be part of the picture. Research on age-related changes in the endocannabinoid system has found that CB1 receptor density declines in certain brain regions with age. Specifically, receptor binding sites were reduced in cortical brain regions of aged subjects, though subcortical regions were relatively spared.15PubMed Central. Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands Cortical regions handle higher-order cognition, perception, and the integration of sensory experience, which are central to how the cannabis high is experienced. Fewer receptors in those areas could mean a qualitatively different or muted response to THC even in someone who has never developed tolerance through heavy use.
Age also brings changes in liver enzyme activity, body composition, and hormonal profiles, all of which compound the receptor-level changes. An older adult with more body fat, lower estradiol, declining liver enzyme function, and fewer cortical CB1 receptors is biologically quite different from their 20-year-old self, even consuming the same product.
Your Gut Microbiome May Alter THC Before It Reaches You
An emerging area of research points to the gut microbiome as another layer of variability in cannabis response, particularly for edibles. The bacteria in your gut can metabolize cannabinoids, potentially altering the potency and duration of their effects before THC even reaches your liver.16PubMed Central. Buds and Bugs: A Fascinating Tale of Gut Microbiota and Cannabis in the Fight against Cancer Gut bacteria can also produce secondary bile acids that activate cannabinoid receptors on their own, adding another variable to the equation. Since everyone’s gut microbiome is different and shifts with diet, antibiotics, and illness, this may help explain why some people consistently get less effect from edibles than others even after accounting for dose, formulation, and liver metabolism.
The research here is still young and mostly drawn from preclinical models and reviews rather than large human trials. But it fits the pattern of cannabis response being a full-body phenomenon, not just a brain-receptor event. If you notice that edibles are unpredictable for you in ways that smoking is not, your gut environment is one plausible variable worth considering.
THC Does Not Only Act on CB1 Receptors
The textbook picture of cannabis focuses on CB1 and CB2 receptors, but THC and other cannabinoids also interact with a family of ion channels called TRP channels. Research has documented that cannabinoids activate TRPV1, TRPV2, TRPV3, TRPV4, TRPM8, and TRPA1 channels with varying effects.17PubMed Central. Diverse TRPV1 responses to cannabinoids These channels are involved in pain perception, temperature sensing, and inflammation.18PubMed. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
Why does this matter for not getting high? Because the subjective cannabis experience is an aggregate of many receptor interactions, not just CB1 activation. Individual variation in TRP channel expression and sensitivity could shift whether the overall experience registers as euphoric, relaxing, uncomfortable, or barely noticeable. Someone with very active TRPV1 channels, for instance, might experience more of the body-sensation side of cannabis without much of the cognitive high. The picture that emerges is that “getting high” is the brain’s summary of dozens of simultaneous receptor events, and the balance of those events varies from person to person in ways science is only beginning to map.
ADHD, Dopamine, and Self-Medication
People with ADHD report using cannabis at higher rates and often describe using it for self-regulation rather than recreation. Research has explored the neural correlates behind this pattern, noting that individuals with ADHD may be at increased risk for cannabis use problems due to deficits in self-regulation, but also that their motivations for use often differ from those of neurotypical users.19PubMed Central. Attention-deficit hyperactivity disorder and therapeutic cannabis use motives Anecdotally, some people with ADHD report that cannabis produces a calming or focusing effect rather than a traditional high. Whether this reflects a genuinely different pharmacological response tied to baseline dopamine signaling or simply a different subjective interpretation of the same effects is not yet settled. But if your experience of cannabis is “it makes me feel normal rather than high,” ADHD or atypical dopaminergic function is worth thinking about.
The First-Time User Problem
One of the most puzzling scenarios is the person who tries cannabis for the very first time and feels nothing at all. This is common enough that researchers have discussed it for decades, though a definitive explanation remains elusive. The leading theories include inhalation technique (new smokers often do not inhale deeply or hold the smoke in the lungs long enough for meaningful absorption), psychological resistance from expectation and anxiety, and the possibility that the endocannabinoid system requires a “priming” exposure before exogenous cannabinoids produce noticeable effects. None of these has been conclusively proven as the sole explanation, and the reality is probably some combination of all three. If your first attempt at smoking cannabis produced nothing, trying again with careful attention to inhalation technique, in a comfortable setting, may give a very different result.
Alternatively, some first-time users who report “nothing happened” did experience physiological effects, such as increased heart rate, dry mouth, or subtle changes in sensory perception, but did not recognize them as a high because they expected something more dramatic. The gap between expectation and reality can mask a genuine pharmacological response, leaving someone convinced their biology is simply not responsive when in fact the drug worked and they just did not notice.